Why the study?
Does direct injection of sTNFR1 expression plasmid DNA reduce infarct size in an experimental rat model of acute myocardial infarction?
Does direct injection of sTNFR1 expression plasmid DNA reduce infarct size in an experimental rat model of acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
In vivo gene transfer of sTNFR1 reduces infarct size and cardiomyocyte apoptosis in a rat model of acute myocardial infarction, suggesting a potential novel therapeutic strategy.
Apoptosis is the major independent form of cardiomyocyte cell death in acute myocardial infarction (AMI). TNF-alpha release early in the course of AMI contributes to myocardial injury, and TNF-alpha induces apoptosis in cardiomyocytes. Soluble TNF-alpha receptor 1 (sTNFR1) is an antagonist to TNF-alpha. However, the effect of sTNFR1 on AMI remains unclear. Here we report that direct injection of an sTNFR1 expression plasmid DNA to the myocardium reduces infarct size in experimental rat AMI. Treatment with sTNFR1 expression plasmid DNA reduced the TNF-alpha bioactivity in the myocardium and the apoptosis of cardiomyocytes. These findings suggest that the anti-TNF-alpha therapy by sTNFR1 can be a new strategy for treatment of AMI.
No takes yet. Share an insight, caveat, or question.
Sugano et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: